115 related articles for article (PubMed ID: 10378766)
1. Identification of PTEN-related sequences in glioma cells and in non-neoplastic cell lines.
Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
Cancer Lett; 1999 Apr; 138(1-2):1-4. PubMed ID: 10378766
[TBL] [Abstract][Full Text] [Related]
2. Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.
Schmidt EE; Ichimura K; Goike HM; Moshref A; Liu L; Collins VP
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1170-83. PubMed ID: 10560660
[TBL] [Abstract][Full Text] [Related]
3. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
[TBL] [Abstract][Full Text] [Related]
4. Functional evaluation of p53 and PTEN gene mutations in gliomas.
Kato H; Kato S; Kumabe T; Sonoda Y; Yoshimoto T; Kato S; Han SY; Suzuki T; Shibata H; Kanamaru R; Ishioka C
Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241
[TBL] [Abstract][Full Text] [Related]
5. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
[TBL] [Abstract][Full Text] [Related]
7. Rare-type mutations of MMAC1 tumor suppressor gene in human glioma cell lines and their tumors of origin.
Zhang SJ; Endo S; Ichikawa T; Yoshimura J; Onda K; Tanaka R; Washiyama K; Kumanishi T
Jpn J Cancer Res; 1999 Sep; 90(9):934-41. PubMed ID: 10551321
[TBL] [Abstract][Full Text] [Related]
8. PTEN mutations in malignant gliomas and their relation with meningeal gliomatosis.
Izumoto S; Ohnishi T; Kanemura H; Arita N; Maruno M; Moriuchi T; Suzuki S; Yoshimine T
J Neurooncol; 2001 May; 53(1):21-6. PubMed ID: 11678426
[TBL] [Abstract][Full Text] [Related]
9. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines.
Ishii N; Maier D; Merlo A; Tada M; Sawamura Y; Diserens AC; Van Meir EG
Brain Pathol; 1999 Jul; 9(3):469-79. PubMed ID: 10416987
[TBL] [Abstract][Full Text] [Related]
10. Method to distinguish between the MMAC1/PTEN gene and its pseudogene in RT-PCR analysis of point mutations.
Liu J; Kagan J
Biotechniques; 1999 Jan; 26(1):19-22, 24. PubMed ID: 9894586
[No Abstract] [Full Text] [Related]
11. Alternative splicing of the human PTEN/MMAC1/TEP1 gene.
Sharrard RM; Maitland NJ
Biochim Biophys Acta; 2000 Dec; 1494(3):282-5. PubMed ID: 11121587
[TBL] [Abstract][Full Text] [Related]
12. Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients.
Zainuddin N; Jaafar H; Isa MN; Abdullah JM
Med J Malaysia; 2004 Oct; 59(4):468-79. PubMed ID: 15779579
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
Fults D; Pedone C
Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
[TBL] [Abstract][Full Text] [Related]
14. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
[TBL] [Abstract][Full Text] [Related]
15. Absence of PTEN/MMAC1 pseudogene in mice.
Kwabi-Addo B; Thompson TC; Ittmann M
DNA Cell Biol; 2000 May; 19(5):301-5. PubMed ID: 10855797
[TBL] [Abstract][Full Text] [Related]
16. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells.
Furnari FB; Huang HJ; Cavenee WK
Cancer Res; 1998 Nov; 58(22):5002-8. PubMed ID: 9823298
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN.
Fujii GH; Morimoto AM; Berson AE; Bolen JB
Oncogene; 1999 Mar; 18(9):1765-9. PubMed ID: 10208437
[TBL] [Abstract][Full Text] [Related]
18. Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells.
Tian XX; Pang JC; To SS; Ng HK
J Neuropathol Exp Neurol; 1999 May; 58(5):472-9. PubMed ID: 10331435
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations.
Zhou XP; Li YJ; Hoang-Xuan K; Laurent-Puig P; Mokhtari K; Longy M; Sanson M; Delattre JY; Thomas G; Hamelin R
Int J Cancer; 1999 Apr; 84(2):150-4. PubMed ID: 10096247
[TBL] [Abstract][Full Text] [Related]
20. Is exon 5 of the PTEN/MMAC1 gene a prognostic marker in anaplastic glioma?
Rustia A; Wierzbicki V; Marrocco L; Tossini A; Zamponi C; Lista F
Neurosurg Rev; 2001 Jul; 24(2-3):97-102. PubMed ID: 11485247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]